1. Home
  2. MIST vs STRW Comparison

MIST vs STRW Comparison

Compare MIST & STRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • STRW
  • Stock Information
  • Founded
  • MIST 2003
  • STRW 2015
  • Country
  • MIST Canada
  • STRW United States
  • Employees
  • MIST N/A
  • STRW N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • STRW Real Estate Investment Trusts
  • Sector
  • MIST Health Care
  • STRW Real Estate
  • Exchange
  • MIST Nasdaq
  • STRW Nasdaq
  • Market Cap
  • MIST 163.2M
  • STRW 151.1M
  • IPO Year
  • MIST N/A
  • STRW N/A
  • Fundamental
  • Price
  • MIST $2.61
  • STRW $12.32
  • Analyst Decision
  • MIST Strong Buy
  • STRW Strong Buy
  • Analyst Count
  • MIST 3
  • STRW 4
  • Target Price
  • MIST $6.33
  • STRW $12.72
  • AVG Volume (30 Days)
  • MIST 2.8M
  • STRW 25.9K
  • Earning Date
  • MIST 11-12-2025
  • STRW 11-06-2025
  • Dividend Yield
  • MIST N/A
  • STRW 5.26%
  • EPS Growth
  • MIST N/A
  • STRW 19.41
  • EPS
  • MIST N/A
  • STRW 0.61
  • Revenue
  • MIST N/A
  • STRW $145,392,000.00
  • Revenue This Year
  • MIST N/A
  • STRW $33.39
  • Revenue Next Year
  • MIST N/A
  • STRW $5.21
  • P/E Ratio
  • MIST N/A
  • STRW $20.03
  • Revenue Growth
  • MIST N/A
  • STRW 29.76
  • 52 Week Low
  • MIST $0.63
  • STRW $8.70
  • 52 Week High
  • MIST $2.75
  • STRW $12.84
  • Technical
  • Relative Strength Index (RSI)
  • MIST 74.94
  • STRW 59.74
  • Support Level
  • MIST $2.31
  • STRW $11.80
  • Resistance Level
  • MIST $2.49
  • STRW $12.27
  • Average True Range (ATR)
  • MIST 0.19
  • STRW 0.39
  • MACD
  • MIST 0.06
  • STRW 0.04
  • Stochastic Oscillator
  • MIST 95.50
  • STRW 74.07

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About STRW Strawberry Fields REIT Inc.

Strawberry Fields REIT Inc is a self-managed and self-administered company that specializes in the acquisition, ownership and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties.

Share on Social Networks: